D081KC00001: Phase I/II Study of MED14736 (Anti-PD-L1 Antibody) in Combination with Olaparib (PARP inhibitor) in Patients with Advanced Solid Tumors (MEDIOLA)

February 17, 2019
https://clinicaltrials.gov/ct2/results?id=NCT02734004
Cancer - Gastro/ Esophageal, Cancer - Breast, Cancer - Gynecologic/ Ovarian, Solid Tumors, Cancer - Gastro, Cancer - Colon Rectal, Cancer - Gastro/ Colorectal
Principal Investigator: Ding Wang, MD
Cancer, Breast Cancer, Ovarian Cancer, Solid tumors, Advanced Solid tumors, Gastric Cancer, Phase 1, Phase 2, Phase I, Phase II, MEDIOLA, MEDI4736, Esophageal cancer, Esophageal, colon rectal, colorectal
Open